(Q43250314)

17 November 2017

Survivin expression in primary malignant melanoma of the esophagus (English)

1 reference

17 November 2017

Satoshi Mamori

1

1 reference

17 November 2017

Fumiaki Kahara

2

1 reference

17 November 2017

Katsuhiro Ohnishi

3

1 reference

17 November 2017

Akihiko Takeda

4

1 reference

17 November 2017

Akihiro Higashida

5

1 reference

17 November 2017

Cho Ashida

6

1 reference

17 November 2017

Hajime Yamada

7

1 reference

17 November 2017

1 January 2009

1 reference

Scandinavian Journal of Gastroenterology

17 November 2017

1 reference

17 November 2017

44

1 reference

17 November 2017

12

1 reference

17 November 2017

1497-1498

1 reference

Primary malignant melanoma of the esophagus: a case report and review of the literature

17 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365520903330310

Survivin as a target for new anticancer interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903330310

Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903330310

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903330310

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365520903330310

10.3109/00365520903330310

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference